Recent News

• 06.10.2025 - Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
• 06.10.2025 - Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
• 06.04.2025 - 45th Annual William Blair Growth Stock Conference
• 06.04.2025 - 45th Annual William Blair Growth Stock Conference
• 05.22.2025 - Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
• 05.22.2025 - Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
• 05.21.2025 - Biodesix to Participate in Upcoming Investor Conferences
• 05.21.2025 - Biodesix to Participate in Upcoming Investor Conferences
• 05.15.2025 - Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS
• 05.15.2025 - Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS

Recent Filings

• 05.30.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.21.2025 - 8-K Current report
• 05.20.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities